BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
Clinical trial NCT00586443 · COMPLETED
Trial details
- NCT number
- NCT00586443
- Sponsor
- Herbert Hurwitz, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2014-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.